Gainers

  • Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday's after-market session. The company's market cap stands at $4.5 million. As per the news, the Q2 earnings report came out today.
  • CytoSorbents (NASDAQ:CTSO) stock moved upwards by 11.11% to $0.4. The company's market cap stands at $22.7 million. As per the news, the Q2 earnings report came out 3 days ago.
  • Mereo BioPharma Group (NASDAQ:MREO) shares rose 8.01% to $0.33. The market value of their outstanding shares is at $43.4 million. As per the news, the Q2 earnings report came out today.
  • LENZ Therapeutics (NASDAQ:LENZ) shares moved upwards by 7.86% to $5.62. The company's market cap stands at $168.0 million. The company's, Q2 earnings came out today.
  • 60 Degrees (NASDAQ:SXTP) stock moved upwards by 7.07% to $1.21. The market value of their outstanding shares is at $3.0 million.
  • Accuray (NASDAQ:ARAY) stock rose 7.0% to $0.31. The market value of their outstanding shares is at $34.9 million.

Losers

  • Edap TMS (NASDAQ:FOCL) stock decreased by 21.8% to $4.7 during Tuesday's after-market session. The market value of their outstanding shares is at $227.8 million.
  • Absci (NASDAQ:ABSI) shares decreased by 16.16% to $7.89. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q2 earnings came out today.
  • WORK Medical Tech Gr (NASDAQ:WOK) shares declined by 10.32% to $2.0. The company's market cap stands at $5.0 million.
  • Concord Medical Services (NYSE:CCM) shares decreased by 9.08% to $4.71. The company's market cap stands at $18.8 million.
  • Apollomics (NASDAQ:APLM) stock fell 7.76% to $17.0. The market value of their outstanding shares is at $39.1 million.
  • Cardiff Oncology (NASDAQ:CRDF) stock fell 7.61% to $0.97. The market value of their outstanding shares is at $80.1 million. As per the news, the Q2 earnings report came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.